They suggested that Pin1 inhibition disrupts the desmoplastic and immunosuppressive tumor microenvironment by acting on CAFs and causing lysosomal degradation of the PD-1 ligand PD-L1 and the gemcitabine transporter ENT1 in cancer cells, rendering pancreatic cancer eradicable by immunochemotherapy [63]. The gene discussed is PIN1; the disease is cancer.